SCHEMBL26042889

SCHEMBL26042889

Cc1ncc2cc(-c3sc(N)nc3-c3cccc(C#N)c3)ccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 2/20 0.45
MAPK1 P28482 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TGFBR1 P36897 2/20 0.43
MAPK14 Q16539 1/20 0.43
ADORA2A P29274 5/20 0.41
MAP4K4 O95819 1/20 0.41
BACE1 P56817 3/20 0.40
BACE2 Q9Y5Z0 2/20 0.40
ADORA1 P30542 1/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
XBP1 P17861 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 4/20 0.39
CYP2D6 P10635 3/20 0.39
CYP2C19 P33261 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366898 0.92 ALDH1A1 (0.45) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL30520050 0.92 ALDH1A1 (0.45) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL30520106 0.84 MAP4K4 (0.46) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL25365761 0.84 MAP4K4 (0.46) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL30520125 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL25365404 0.83 ALDH1A1 (0.47) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL25366229 0.80 MAP4K4 (0.56) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL30519914 0.80 MAP4K4 (0.56) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL25367687 0.80 TGFBR1 (0.47) ALDH1A1MAPTLMNAMAPK1MEN1
SCHEMBL30520035 0.80 TGFBR1 (0.47) ALDH1A1MAPTLMNAMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144559-A1 ANTAGONIST OF ADENOSINE RECEPTORS AdoRx Therapeutics Limited (GB) 2023-08-03 WO disclosed